Insider · CIK 0001228684
LINK WILLIAM J PHD
Reports to the SEC for 14 companies · IRVINE, CA
Transactions
50
Companies
14
Filings
8
CIK
0001228684
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-15 | TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2026-09-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$915K |
| 2026-09-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$60K |
| 2026-09-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$5,280.66 |
| 2026-09-15 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-06-25 | TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2026-06-25 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2026-06-25 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2026-06-17 | RXSTRxSight, Inc.A Award | — |
| 2026-06-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$655K |
| 2026-06-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$121K |
| 2026-06-12 | TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2026-06-12 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-06-03 | LNSRLENSAR, Inc.A Award | — |
| 2026-03-16 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$247K |
| 2026-03-16 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$578K |
| 2026-03-16 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$34.4K |
| 2025-12-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$408K |
| 2025-12-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$516K |
| 2025-12-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$94.6K |
| 2025-12-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$458K |
| 2025-12-15 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$388K |
| 2025-09-16 | TARSTarsus Pharmaceuticals, Inc.G Gift | — |
| 2025-09-08 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$1.55M |
| 2025-06-13 | TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2025-06-13 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-06-12 | TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-12 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2025-06-03 | RXSTRxSight, Inc.A Award | — |
| 2025-05-23 | LNSRLENSAR, Inc.A Award | — |
| 2024-08-12 | TARSTarsus Pharmaceuticals, Inc.J Other | — |
| 2024-08-12 | TARSTarsus Pharmaceuticals, Inc.J Other | — |
| 2024-08-12 | TARSTarsus Pharmaceuticals, Inc.J Other | — |
| 2024-08-12 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$780K |
| 2024-08-12 | TARSTarsus Pharmaceuticals, Inc.S Sale | −$133K |
| 2024-06-24 | TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2024-06-24 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-06-13 | TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-13 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2024-06-06 | RXSTRxSight, Inc.A Award | — |
| 2024-05-07 | LNSRLENSAR, Inc.A Award | — |
| 2024-02-01 | RXSTRxSight, Inc.S Sale | −$1.02M |
| 2024-02-01 | RXSTRxSight, Inc.S Sale | −$383K |
| 2024-02-01 | RXSTRxSight, Inc.G Gift | — |
| 2023-08-17 | RXSTRxSight, Inc.J Other | — |
| 2023-08-17 | RXSTRxSight, Inc.J Other | — |
| 2023-08-17 | RXSTRxSight, Inc.J Other | — |
| 2023-06-22 | TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-22 | TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2023-06-16 | TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion | — |
Recent filings
- 4LINK WILLIAM J PHD0001228684-26-000010SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001228684-26-000008SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001193125-26-275841SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001228684-26-000006SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001228684-26-000004SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001193125-26-259985SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001228684-26-000002SEC(opens sec.gov)
- 4LINK WILLIAM J PHD0001228684-25-000005SEC(opens sec.gov)
Companies
- ABBOTT MEDICAL OPTICS INCDirector
- Edwards Lifesciences CorpDirectorEW
- Flexion Therapeutics Inc10% Owner
- GENOMIC HEALTH INC10% Owner
- GLAUKOS CorpDirectorGKOS
- HELICOS BIOSCIENCES CORP10% Owner
- Inogen Inc10% OwnerINGN
- INTRALASE CORPDirector
- LENSAR, Inc.DirectorLNSR
- Oyster Point Pharma, Inc.Director
- PHASERX, INC.10% Owner
- RxSight, Inc.DirectorRXST
- Tarsus Pharmaceuticals, Inc.DirectorTARS
- Vivani Medical, Inc.DirectorVANI
Address
C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4
IRVINE, CA, 92618